Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Argus Research Downgrades Nike to Hold

Argus Research Downgrades Nike to Hold

Argus Research analyst John Staszak downgrades Nike (NYSE:NKE) from Buy to Hold.

October 3, 2022

1 minute read

Argus Research analyst John Staszak downgrades Nike (NYSE:NKE) from Buy to Hold.

Cannabis Milestone: Over-The-Counter Medical Marijuana Launches In Georgia Pharmacies

October 30, 10:10 AM

The new program will put about 90% of Georgia's population within a 30-minute drive of a pharmacy that sells medical marijuana.

November 1, 2:28 PM

https://www.scribd.com/document/604401115/Workhorse-Patent

May 28, 9:52 AM

XPeng shares see a slight increase as anticipation builds around the unveiling of the first model from its sub-brand, Mona.

August 11, 6:38 AM

Piper Sandler analyst Jeff Garro maintains Bright Health Gr (NYSE:BHG) with a Overweight and lowers the price target from $5 to $3.